Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $63,577.67 -0.08%
Ethereum $1,665.10 -1.02%
BNB $603.95 -0.07%
Optimism $0.10 +5.20%
Arbitrum $0.08 +0.20%
Solana $66.70 -0.32%
Polygon $0.22 +2.77%
Cosmos $1.96 -1.15%
Avalanche $6.59 -1.16%

Bitcoin $63,577.67 -0.08%
Ethereum $1,665.10 -1.02%
BNB $603.95 -0.07%
Optimism $0.10 +5.20%
Arbitrum $0.08 +0.20%
Solana $66.70 -0.32%
Polygon $0.22 +2.77%
Cosmos $1.96 -1.15%
Avalanche $6.59 -1.16%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B